Jakafi 10 MG tablet 60S

Ended Awarded

Contract number
SPE2DB25FYN93
Awardee
Awarding agency
Obligated
$12,116

Award facts

Contract value 100% obligated
$12,115.65 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $12,115.65, is for the delivery of 60 tablets of the prescription drug Jakafi (ruxolitinib) 10 mg. The contract has an ultimate completion date of April 30, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting the medical supply needs of military health facilities worldwide. This contract award demonstrates DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to the Department of Defense healthcare system.

Quick answers

Who was awarded contract SPE2DB25FYN93?

SPE2DB25FYN93 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 29, 2025.

How much is contract SPE2DB25FYN93 worth?

The government has obligated $12,116 on SPE2DB25FYN93.

Is contract SPE2DB25FYN93 an order under another contract?

Yes. SPE2DB25FYN93 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.

Was contract SPE2DB25FYN93 competed?

The extent of competition for SPE2DB25FYN93 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award